Two classic oncogene mutations in NSCLC are epidermal growth factor receptor (EGFR) mutation or anaplastic lymphoma kinase (ALK) chromosome rearrangement (the most common one is EML4-ALK fusion) (52). The gene discussed is EML4; the disease is non-small cell lung carcinoma.